ABAC THERAPEUTICS
ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximize the chance of success in clinical development.
ABAC THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2014-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.abactherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(+34) 93 230 11 54
Total Funding:
16 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Grupo Ferrer Internacional
Grupo Ferrer Internacional investment in Series A - ABAC Therapeutics
Global health sciences venture fund
Global health sciences venture fund investment in Series A - ABAC Therapeutics
Pontifax
Pontifax investment in Series A - ABAC Therapeutics
Caixa Capital Risc
Caixa Capital Risc investment in Series A - ABAC Therapeutics
Debiopharm Innovation Fund
Debiopharm Innovation Fund investment in Series A - ABAC Therapeutics
Official Site Inspections
http://www.abactherapeutics.com Semrush global rank: 6.15 M Semrush visits lastest month: 1.31 K
Unable to get host informations!!!
